Morgan Stanley (NYSE:MS) has been upgraded to a “Buy” rating by analysts at UBS, who cited the firm’s strong profitability, growth catalysts, and positioning in wealth management as reasons for a more positive outlook despite ongoing market uncertainty.
The analysts raised their rating from “Neutral” and set a 12-month price target of $196, implying upside of about 18% from the stock’s price at their time of writing.
UBS framed the upgrade within a broader macro environment marked by geopolitical tensions, evolving credit markets, and technological disruption. “Given the recent barrage of headlines hitting the market and bank stocks (Iran conflict, private credit, AI disruption), we think it's an opportunity for investors to add quality stocks in their portfolios,” they wrote. “In an uncertain world, buy quality.”
They stressed that Morgan Stanley’s valuation may not appear inexpensive on traditional metrics but argued that its underlying performance justifies a premium. “Given best-in-class profitability, MS shares will unlikely ever screen optically inexpensive,” the analysts said, adding that current conditions present “an attractive buying opportunity.”
UBS pointed to several potential catalysts that could support the bank’s share performance, including strength in advisory services, the prospect of large initial public offerings, and continued momentum in its wealth management division. The firm also forecast earnings per share of $11.75 for 2026 and $12.60 for 2027.
The analysts highlighted what they see as a disconnect between Morgan Stanley and some of its closest peers, particularly Goldman Sachs.
They also underscored the company’s track record of strategic transformation, including acquisitions such as E*TRADE, and its potential to benefit from advances in artificial intelligence.
“Given MS's history of inorganic and organic growth moves, we think the company is unafraid to disrupt itself,” the analysts wrote, adding that “MS should be a net winner in the AI evolution within the wealth business.”
Regulatory dynamics were another factor cited in the report. UBS suggested that Morgan Stanley may not yet have fully benefited from industry-wide deregulation trends, in contrast to peers. “We think that de-reg has yet to be priced into MS shares vs. peers,” the analysts wrote.
In wealth management, UBS expressed confidence that profitability targets could prove conservative. “We think the market isn't appreciating how active capital markets accelerates net new asset growth, as liquidity events naturally flow into the advisory funnel,” the analysts added.